Literature DB >> 24363072

Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database.

Thomas D Koepsell1, Dawn P Gill, Baojiang Chen.   

Abstract

Many new therapies for dementia target a specific pathologic process and must be applied early. Selection of specific therapy is based on the clinical etiologic diagnosis. We sought to determine the stability of the clinical etiologic diagnosis over time and to identify factors associated with instability. We identified 4141 patients with dementia or mild cognitive impairment who made at least 2 visits approximately a year apart to a dementia research center, receiving a clinical etiologic diagnosis on each visit. We assessed concordance of etiologic diagnoses across visits, κ-statistics, and transition probabilities among diagnoses. The primary clinical etiologic diagnosis remained stable for 91% of patients but with a net shift toward dementia with Lewy bodies and Alzheimer's disease. Lower diagnostic stability was significantly associated with older age, nonwhite race, milder disease at presentation, more underlying conditions contributing to cognitive decline, lack of a consistent spouse/partner informant, and being evaluated by different clinicians on different visits. Multistate Markov modeling generally confirmed these associations. Clinical etiologic diagnoses were generally stable. However, several readily ascertained characteristics were associated with higher instability. These associations may be useful to clinicians for anticipating when an etiologic diagnosis may be more prone to future change.

Entities:  

Keywords:  dementia diagnosis; dementia etiology; diagnosis stability

Mesh:

Year:  2013        PMID: 24363072      PMCID: PMC3876285          DOI: 10.1177/1533317513504611

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  17 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Marginal structural models as a tool for standardization.

Authors:  Tosiya Sato; Yutaka Matsuyama
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

4.  DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Todd N Eagar; Olaf Stüve; Roger N Rosenberg
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

5.  Mapping out biomarkers for Alzheimer disease.

Authors:  Monique M B Breteler
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

6.  Report of the task force on designing clinical trials in early (predementia) AD.

Authors:  P S Aisen; S Andrieu; C Sampaio; M Carrillo; Z S Khachaturian; B Dubois; H H Feldman; R C Petersen; E Siemers; R S Doody; S B Hendrix; M Grundman; L S Schneider; R J Schindler; E Salmon; W Z Potter; R G Thomas; D Salmon; M Donohue; M M Bednar; J Touchon; B Vellas
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

7.  The value of informant versus individual's complaints of memory impairment in early dementia.

Authors:  D B Carr; S Gray; J Baty; J C Morris
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  Validation of consensus panel diagnosis in dementia.

Authors:  Matthew J Gabel; Norman L Foster; Judith L Heidebrink; Roger Higdon; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; James R Burke; Christopher M Clark; Steven T Dekosky; Martin R Farlow; William J Jagust; Claudia H Kawas; Robert A Koeppe; James B Leverenz; Anne M Lipton; Elaine R Peskind; R Scott Turner; Kyle B Womack; Edward Y Zamrini
Journal:  Arch Neurol       Date:  2010-12

9.  Informant-based dementia screening in a population-based sample of African Americans.

Authors:  Theodore K Malmstrom; Douglas K Miller; Mary A Coats; Pamela Jackson; J Philip Miller; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

10.  Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Authors:  S Gilman; M Koller; R S Black; L Jenkins; S G Griffith; N C Fox; L Eisner; L Kirby; M Boada Rovira; F Forette; J-M Orgogozo
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

View more
  7 in total

Review 1.  Clinical workout for the early detection of cognitive decline and dementia.

Authors:  M Tsolaki
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

2.  Memory improvement in African Americans with amnestic mild cognitive impairment.

Authors:  Barry W Rovner; Robin J Casten; Benjamin Leiby
Journal:  Int J Geriatr Psychiatry       Date:  2019-06-18       Impact factor: 3.485

3.  Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.

Authors:  Daniela Koller; Tammy Hua; Julie P W Bynum
Journal:  J Am Geriatr Soc       Date:  2016-06-24       Impact factor: 5.562

4.  Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Margaret Heslin; Daniel Stahl; Zera Brittenden; Edgardo Caverzasi; Philip McGuire; William T Carpenter
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

5.  Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; David P Breen; Tien K Khoo; Caroline H Williams-Gray; Roger A Barker; David J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-03-01       Impact factor: 10.154

6.  Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders.

Authors:  Pei-Hao Chen; Shih-Jung Cheng; Hui-Chi Lin; Chuo-Yu Lee; Chih-Ho Chou
Journal:  Behav Neurol       Date:  2018-06-05       Impact factor: 3.342

Review 7.  Application of Optical Coherence Tomography in the Detection and Classification of Cognitive Decline.

Authors:  Moon J Lee; Alison G Abraham; Bonnielin K Swenor; A Richey Sharrett; Pradeep Y Ramulu
Journal:  J Curr Glaucoma Pract       Date:  2018-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.